We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

This study is currently recruiting participants.
Verified January 2017 by GlaxoSmithKline
Sponsor:
ClinicalTrials.gov Identifier:
NCT01342952
First Posted: April 27, 2011
Last Update Posted: January 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
GlaxoSmithKline
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2024
  Estimated Primary Completion Date: October 2022 (Final data collection date for primary outcome measure)